Delivery Order W911QY11D0054-0009
Award Date
4/14/16
Potential Completion Date
4/24/19
Potential Value
$2.7M
Funding Federal Agency
Bureau of Medicine and Surgery
Contracting Federal Agency
ACC Aberdeen Proving Ground
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC Category
R499 - Support- Professional: Other
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Albuquerque, NM 87108, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Air Education and Training Command, a defense agency, to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of Lovelace Biomedical Research Institute. The contract, valued at $794,540.92, is for Department of Clinical Investigation research support services under the Navy Medicine R&D Support Omnibus III contract vehicle. LBERI, a non-profit organization, provides preclinical research services to support the...
This is a delivery order awarded by the Department of the Air Force to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), doing business as Inhalation Toxicology Research Institute, a not-for-profit contract research organization. The $1,190,719.36 firm fixed-price order was issued under the Navy Medicine R&D Support Omnibus III (OMNIBUS III / O3-127AF) indefinite delivery, indefinite quantity (IDIQ) contract. The order is for pain management program management support...
This is a delivery order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Lovelace Biomedical and Environmental Research Institute, Inc. (doing business as Inhalation Toxicology Research Institute), a subsidiary of Lovelace Biomedical Research Institute. The $1,413,201.00 cost-plus-fixed-fee contract provides clinical research support services in support of audiological research at the Walter Reed National Military Medical Center. The...
This federal contract award, valued at $1,403,705.20, was issued by the Food and Drug Administration (FDA) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of Lovelace Biomedical Research Institute. The contract is a delivery order issued under the Tobacco Products Pharmacology Study master indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle. The contract does not have a set-aside designation. LBERI, a non-profit contract research organization,...
This is a delivery order awarded under the Navy Medicine R&D Support Omnibus III multiple-award contract vehicle to Lovelace Biomedical and Environmental Research Institute, Inc., a subsidiary of the Lovelace Biomedical Research Institute. The $4,707,730.75 cost-plus-fixed-fee order provides disease surveillance and clinical study support services for the Naval Health Research Center's Project X. The work will be performed in San Diego, California and has an ultimate completion date of...
This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of Lovelace Biomedical Research Institute. The $203,807.96 contract is a delivery order for Task Area A under the Pharmacology-Toxicology Core Lab task order 7 of the NHLBI's Gene Therapy Resource Program (GTRP). The work, which has no set-aside designation,...
This is a $897,471 firm-fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), doing business as Inhalation Toxicology Research Institute. The contract is part of a larger In Vivo Toxicology of Tobacco 2015-2020 indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle. LBERI, a non-profit contract research organization, will provide preclinical research services to support the...
This is a delivery order contract awarded by the Department of Health and Human Services Food and Drug Administration to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a non-profit organization, for a project titled "CYTOTOXICITY OF COMMON SOLVENTS USED IN LIQUID NICOTINE FORMULATIONS". The contract has a potential value of $1,149,919.00 and a completion date of April 15, 2021. This delivery order is part of a larger indefinite delivery/indefinite quantity...
This is a delivery order contract awarded by the Food and Drug Administration (FDA) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a non-profit research organization, to develop a standard guideline protocol for rodent tobacco smoke inhalation studies. The contract has a ceiling value of $1,373,599.00 and is a firm fixed-price task order issued under the "In Vivo Toxicology of Tobacco 2015-2020" indefinite-delivery, indefinite-quantity (IDIQ) contract. The...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to the Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract is for natural history studies in neuromuscular junction (NMJ) disease mouse models, with a period of performance from September 28, 2020 to December 31, 2021 and a total ceiling value of $2,366,151.00. The contract does not have a set-aside...